Advanced Practice Midwife in Lancaster, PA Accepting Medicare

8 Advanced Practice Midwife nurses found. Showing 1 - 8

Brittany Walp, CNM Advanced Practice Midwife Medicare: Medicare Enrolled Practice Location: 694 Good Dr Ste 112, Lancaster, PA 17601 Phone: 717-397-8177

Lisa L Kelly, CRNP Advanced Practice Midwife Medicare: Accepting Medicare Assignments Practice Location: 694 Good Dr, Suite 11, Lancaster, PA 17601 Phone: 717-544-3737    Fax: 717-544-3739

Amanda Leigh Fowler, CNM Advanced Practice Midwife Medicare: Medicare Enrolled Practice Location: 333 N Arch St, Lancaster, PA 17603 Phone: 717-945-1559    Fax: 717-945-1587

Ms. Ann A. Moore, MIDWIFE Advanced Practice Midwife Medicare: Not Enrolled in Medicare Practice Location: 31 S Lime St, Lancaster, PA 17602 Phone: 717-299-2891

Kristen M Harker, CRNP CNM Advanced Practice Midwife Medicare: Medicare Enrolled Practice Location: 802 New Holland Ave Ste 200, Lancaster, PA 17602 Phone: 717-299-6371    Fax: 717-945-1587

Mrs. Mary E. Mclane, C.N.M. Advanced Practice Midwife Medicare: Not Enrolled in Medicare Practice Location: 123 S Christian St, Lancaster, PA 17602 Phone: 717-413-6742    Fax: 717-391-6593

Christina Jeanne Bewersdorff, CNM Advanced Practice Midwife Medicare: Medicare Enrolled Practice Location: 694 Good Dr, Lancaster, PA 17601 Phone: 717-677-2404

Cheryl Ann Gard, CNM, CRNP Advanced Practice Midwife Medicare: Accepting Medicare Assignments Practice Location: 2128 Embassy Dr, Suite B, Lancaster, PA 17603 Phone: 717-509-5090    Fax: 717-509-5078

News Archive

JIB highlights aluminium's potential role in neurodegenerative diseases

Aluminium's potential role in neurodegenerative diseases such as Alzheimer's disease and cancer, specifically breast cancer, and the potential role for aluminium adjuvants in vaccine-related adverse effects are spotlighted in the latest issue of the Journal of Inorganic Biochemistry (JIB).

Researchers highlight potential therapy for treating rare, deadly blood-clotting disorder

In proof-of-concept experiments, University of Alabama at Birmingham researchers have highlighted a potential therapy for a rare but potentially deadly blood-clotting disorder, TTP.

Reform law gives major boost to community health centers, medical homes

The Washington Post: "The health-care legislation signed into law in March provides a major boost to community health centers: $11 billion over five years. The first of these federally supported primary-care clinics opened in 1965." The law also provides funding designed to increase the supply of primary-care providers. And, "[o]n Wednesday, Secretary of Health and Human Services Kathleen Sebelius announced that the federal government will spend $250 million in programs to increase the number of doctors, nurses and other care providers.

BeiGene doses first patient in Phase 1 study of BGB-283

BeiGene (Beijing), Co., Ltd., today announced dose administration for the first patient in a Phase 1 study of BGB-283 in patients with B-RAF or K-RAS mutations. BGB-283 is an investigational, oral, selective, potent second generation inhibitor of B-RAF, making it a targeted therapeutic candidate to potentially treat and bring benefit to patients with cancers that harbor BRAF mutations and/or aberrations in the RAS-MAPK (mitogen-activated protein kinase) pathway.

Read more Medical News

› Verified 1 days ago